Transdermal Diagnosis of Malaria Using Vapor Nanobubbles. by Lukianova-Hleb, Ekaterina et al.
Lukianova-Hleb, E; Bezek, S; Szigeti, R; Khodarev, A; Kelley, T;
Hurrell, A; Berba, M; Kumar, N; D’Alessandro, U; Lapotko, D (2016)
Transdermal Diagnosis of Malaria Using Vapor Nanobubbles Response.
Emerging infectious diseases, 22 (2). p. 344. ISSN 1080-6040 DOI:
10.3201/eid2202.151829
Downloaded from: http://researchonline.lshtm.ac.uk/2534027/
DOI: 10.3201/eid2202.151829
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
  4. Rebelo M, Tempera C, Bispo C, Andrade C, Gardner R,  
Shapiro HM, et al. Light depolarization measurements in malaria: 
A new job for an old friend. Cytometry A. 2015;87:437–45.  
http://dx.doi.org/10.1002/cyto.a.22659
  5. Rebelo M, Shapiro HM, Amaral T, Melo-Cristino J, Hänscheid T.  
Haemozoin detection in infected erythrocytes for Plasmodium 
falciparum malaria diagnosis-prospects and limitations.  
Acta Trop. 2012;123:58–61. http://dx.doi.org/10.1016/ 
j.actatropica.2012.03.005
Address for correspondence: Thomas Hänscheid, Instituto de Medicina 
Molecular, Faculdade de Medicina de Lisboa, Av Prof Egas Moniz, 
P-1649-028 Lisbon, Portugal; email: t.hanscheid@medicina.ulisboa.pt
In Response:
Ekaterina Lukianova-Hleb, Sarah Bezek,  
Reka Szigeti, Alexander Khodarev,  
Thomas Kelley, Andrew Hurrell, Michail Berba, 
Nirbhay Kumar, Umberto D’Alessandro,  
Dmitri Lapotko
Author affiliations: Rice University, Houston, Texas, USA 
(E. Lukianova-Hleb, D. Lapotko); Baylor College of Medicine, 
Houston (S. Bezek, R. Szigeti); Ben Taub General Hospital, Harris 
Health System, Houston (S. Bezek, R. Szigeti); X Instruments 
LLC, Fremont, California, USA (A. Khodarev); Precision  
Acoustics Ltd, Dorset, England, UK (T. Kelley, A. Hurrell); Standa 
UAB, Vilnius, Lithuania (M. Berba); Tulane University, New 
Orleans, Louisiana, USA (N. Kumar); Medical Research Council, 
Banjul, The Gambia (U. D’Alessandro); London School of Hygiene 
and Tropical Medicine, London, UK (U. D’Alessandro)
DOI: http://dx.doi.org/10.3201/eid2202.151829
In Response: The letter by Rebelo et al. (1) that ques-
tions our previously described noninvasive malaria diag-
nostics (2,3) misinterprets both articles. The main objec-
tion comes to our alleged call for “large-scale studies in 
humans”; no such statement appeared in our 2014 article 
(2), and in the 2015 article (3), we clearly stated that large-
scale studies will be considered after the optimization of a 
new prototype and improving its sensitivity. The authors’ 
final questioning of our eligibility for resources is a nonsci-
entific opinion.
Concerning the quality of the standard clinical diagno-
sis, both thin blood film analysis and rapid diagnostic test 
results were obtained in a certified US clinical laboratory 
and returned consistent data. The lack of re-evaluation of 
the patient and the diagnostic timing are indeed limitations 
but were caused by the clinical restrictions. Our goal in the 
2015 article (3) was to demonstrate the first noninvasive 
diagnosis of malaria in a human, which was achieved. The 
additional parameters discussed in the letter were not the 
subject of this study. Their letter further misinterprets our 
2014 study, stating that parasitemia was virtual in that ar-
ticle; in fact, we studied actual infections among mice (2).
The criticism of Rebelo et al. might have been fueled 
by their own limited detection of hemozoin with flow cy-
tometry and microscopy (4), in which they used parasite 
cultures and an unspecified number of malaria patients. 
That the methods they used might not have performed well 
does not mean that the novel technology we described, 
based upon a different mechanism, would have the same 
limitations in detecting hemozoin.
In conclusion, we agree with the need for optimization 
of the technology and additional testing. We are currently 
developing and testing our technology in a malaria-endem-
ic country. Nevertheless, the letter by Rebelo et al. does not 
alter the fact that our novel noninvasive malaria diagnostic 
technology worked in a human.
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